Adalimumab Treatment in a Case of Treatment-Resistant Acne Conglobata

Munise Daye; Şeyma Kaya Bulut

doi:10.58600/eurjther2220

Authors

Munise Daye Department of Dermatology, Faculty of Medicine, Necmettin Erbakan University, Konya, Türkiye https://orcid.org/0000-0002-6614-1821
Şeyma Kaya Bulut Department of Dermatology, Faculty of Medicine, Necmettin Erbakan University, Konya, Türkiye https://orcid.org/0009-0000-5312-6502

DOI:

https://doi.org/10.58600/eurjther2220

Keywords:

Acne, Adalimumab, TNF alfa

Metrics

Metrics Loading ...

References

Yiu ZZ, Madan V, Griffiths CE (2015) Acne conglobata and adalimumab: use of tumour necrosis factor-alpha antagonists in treatment-resistant acne conglobata, and review of the literature. Clin Exp Dermatol 40:383-386. https://doi.org/10.1111/ced.12540

Gollnick HP (2015) From new findings in acne pathogenesis to new approaches in treatment. J Eur Acad Dermatol Venereol 29 Suppl 5:1-7. https://doi.org/10.1111/jdv.13186

Graham GM, Farrar MD, Cruse-Sawyer JE, Holland KT, Ingham E (2004) Proinflammatory cytokine production by human keratinocytes stimulated with Propionibacterium acnes and P. acnes GroEL. Br J Dermatol 150:421-428. https://doi.org/10.1046/j.1365-2133.2004.05762.x

Ferahbaş Kesikoğlu A (2020) Akne Klinik. Turkderm 54:4-8. https://doi.org/10.4274/turkderm.galenos.2020.26964

Nast A, Dréno B, Bettoli V, Bukvic Mokos Z, Degitz K, Dressler C, Finlay AY, Haedersdal M, Lambert J, Layton A (2016) European evidence‐based (S3) guideline for the treatment of acne–update 2016–short version. J Eur Acad Dermatol Venereol. 30:1261-1268. https://doi.org/10.1111/jdv.13776

Sand FL, Thomsen SF (2013) Adalimumab for the treatment of refractory acne conglobata. JAMA Dermatol 149:1306-1307. https://doi.org/10.1001/jamadermatol.2013.6678